What Parents Want You to Know About Repeated Glucose Monitoring for Children at Diabetes Risk

Type 1 diabetes develops in stages. Some children show signs of autoimmunity—when the body's immune system starts attacking insulin-producing cells—long before symptoms appear. Researchers want to track these children closely to understand disease progression and test new prevention approaches.

Continuous glucose monitors (CGMs) are small sensors that track blood sugar patterns in real time. In this study, children at risk for type 1 diabetes wore blinded Dexcom G6 sensors—meaning the data was hidden from families during wear. Researchers recently asked parents: What was this experience actually like for you and your family?

Nineteen parents—mostly mothers—shared their experiences. Their children averaged 7.5 years old and had worn the CGM devices multiple times over the study period.

Parents described several concrete challenges. Sensor insertion could be painful or cause anxiety in children. Some parents worried about losing data if a sensor fell off or malfunctioned. These are the everyday hurdles families navigate when participating in research monitoring—hurdles that aren't always visible in published results.

How and when parents received feedback about their child's glucose patterns shaped their whole experience. Parents wanted clear, timely explanations from their healthcare team—especially as their child's risk status changed. When communication was strong, it reduced uncertainty; when it was unclear, it left parents confused or anxious.

This finding underscores something researchers sometimes overlook: providing data is not enough. Families need interpretation, context, and honest conversation about what the numbers mean for their child's future.

Despite the hassles, most parents said knowing their child's risk was valuable. When children eventually developed clinical type 1 diabetes (Stage 3), parents who had been monitored felt prepared. They understood what was coming. They could arrange care, educate themselves, and support their child through diagnosis.

Parents described this preparation as empowering rather than frightening. Knowing allowed them to move from shock and confusion to informed action—a distinction that matters for family wellbeing.

This small, qualitative study gathered lived experience rather than test scores or outcomes. Its findings are limited to these 19 families and cannot be generalized to all families. However, the themes highlight what matters to parents navigating early-stage diabetes detection: honest communication, practical support during monitoring, and advance knowledge of risk.

As research in type 1 diabetes prevention expands, these insights can help teams design studies and monitoring programs that fit into families' real lives—not just clinic timelines.

Source: Diabetic medicine : a journal of the British Diabetic Association. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.